Andreas Pahl

Andreas Pahl

Chief Executive Officer en HEIDELBERG PHARMA AG .

Health Technology
Consumer Services
Commercial Services

Perfil

Andreas Pahl occupies the position of Chief Executive Officer at Heidelberg Pharma AG and Managing Director at Heidelberg Pharma Research GmbH (a subsidiary of Heidelberg Pharma AG).
In the past he occupied the position of Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd.
and Head-Late Pharmacology at Nycomed GmbH (a subsidiary of Takeda Pharmaceutical Co., Ltd.), Chief Scientific Officer of Heidelberg Pharma AG, Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg and Professor at Technical University of Berlin.
He received an undergraduate degree from Humboldt-Universität zu Berlin.

Cargos activos de Andreas Pahl

EmpresasCargoInicio
HEIDELBERG PHARMA AG Chief Executive Officer 01/02/2024
Chief Executive Officer 01/02/2024
Todos los cargos activos de Andreas Pahl

Antiguos cargos conocidos de Andreas Pahl.

EmpresasCargoFin
Nycomed GmbH Corporate Officer/Principal -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal -
Director/Board Member -
Friedrich-Alexander University of Erlangen-Nuremberg Corporate Officer/Principal -
Technical University of Berlin Corporate Officer/Principal -
Ver el detalle de la experiencia de Andreas Pahl.

Formación de Andreas Pahl.

Humboldt-Universität zu Berlin Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andreas Pahl.

Relaciones

20

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
TAKEDA PHARMACEUTICAL COMPANY LIMITED

Health Technology

HEIDELBERG PHARMA AG

Health Technology

Empresas privadas4
Nycomed GmbH

Commercial Services

Health Technology

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa
  2. Insiders
  3. Andreas Pahl